Abstract

Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas

Author(s): Choo Winnie

Issue: Jul/Aug 2017 - Volume 21, Number 4

Page(s): 282-289

Download in electronic PDF format for $75
  • Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas Page 1
  • Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas Page 2
  • Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas Page 3
  • Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas Page 4
  • Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas Page 5
  • Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas Page 6
  • Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas Page 7
  • Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas Page 8

Abstract

The discovery of beta-adrenergic blocker effects on infantile hemangiomas has affected the choice of treatment in recent years. Oral propranolol is effective in treating infantile hemangiomas, but the risk of systemic side effects remains a concern. Data from literature review reported positive clinical outcomes with no major adverse effects observed in children using topical beta-blocker such as timolol maleate. Topical application of timolol eye drop has been mentioned in few studies, most of which reported that the solution cannot stay on the site of application due to its fluidity. Adding hydroxyethyl cellulose into a timolol solution increased its viscosity by forming a hydrogel and thus changed the rheology property. The compounded timolol gel exhibited thixotropy property allowing better and longer contact at sites of application. Experimental data from literature review showed desirable characteristics and measurable flux of timolol across human stratum corneum. Gel dosage form allows easy and precise application and maximizes timolol’s therapeutic efficacy at the sites of application.

Related Keywords

  • infantile hemangioma
  • strawberry birthmark
  • beta-adrenergic antagonists
  • beta blockers
  • timolol maleate
  • topical preparation
  • infants
  • children
  • formulation
  • timolol eye drops
  • 2-hydroxyethyl cellulose
  • transdermal permeability
  • skin permeation
  • stability
  • sterility
  • microbial contamination

Related Categories

  • DERMATOLOGY
  • FORMULATIONS
  • PEDIATRICS
  • ADVERSE DRUG EVENTS
  • DOSAGE FORMS/DRUG CARRIERS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2017
Pg. 282-289
Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas
Author(s): Choo Winnie
Nov/Dec 2011
Pg. 458-463
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Author(s): Zur Eyal
Sep/Oct 2022
Pg. 364-368
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Author(s): Riepl Mike
May/Jun 2020
Pg. 194-197
Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality
Author(s): Hagan John C III, Everett Eric, Chamberlain Tyler
Mar/Apr 2023
Pg. 153
Timolol 0.125%/Mucolox 15%/0.9% Normal Saline Nasal Spray
Author(s): Allen Loyd V Jr
Sep/Oct 2011
Pg. 358-366
Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride
Author(s): Zur Eyal
Mar/Apr 2018
Pg. 147
Dorzolamide 2% and Timolol 0.5% Ophthalmic Solution
Author(s): Allen Loyd V Jr
Mar/Apr 2025
Pg. 132-140
Formulation and Characterization of Ophthalmic in Situ Gel Forming Solution of Timolol Maleate for Glaucoma
Author(s): Rajagopal Kumaravelrajan, Kanmani Gokul, Venkatesan Suba, Palanivelu Amudha
Jul/Aug 2016
Pg. 328-332
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures
Author(s): Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE
Nov/Dec 2009
Pg. 506-515
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis
Author(s): Mixon William, Angelle Patricea (Patsy), Chang Richard I
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
Sep/Oct 2014
Pg. 418-426
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation
Author(s): Robert Marie-Claude, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H
Sep/Oct 2019
Pg. 418-421
Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5%
Author(s): Berisa Prado Silvia, Riestra Ayora Ana Cristina, Trelles Campa Adrián
Nov/Dec 2017
Pg. 481-486
Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations
Author(s): Allen Loyd V Jr
Nov/Dec 2022
Pg. 480-488
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Author(s): Riepl Mike
Mar/Apr 2024
Pg. 129
Addendum to Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine A New Therapeutic Modality
Author(s):
Nov/Dec 2009
Pg. 540-543
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops
Author(s): Reed-Kane Dana, Carlson Rachel A, Kupiec Thomas C, Vu Nicole
Jul/Aug 2024
Pg. 286-290
Acute Migraine Treatment with Timolol 0.5% Nasal Spray - Compounding Pharmacists Have an Important Role
Author(s): Hagan John C III, Kosa Steven C, Chamberlain Tyler
Sep/Oct 2018
Pg. 358-366
Current Trends and Emerging Priorities in Compounded Preparations for Children
Author(s): Parrish Richard H II
Sep/Oct 2016
Pg. 399-404
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Author(s): Allen Loyd V Jr